Nauru vs South Asia (IDA & IBRD): Immunization, measles second dose
Nauru
99.0%
in 2024
South Asia (IDA & IBRD)
92.2%
in 2024
Nauru rank
1st
South Asia (IDA & IBRD) rank
3rd
Immunization, measles second dose over time
- Nauru
- South Asia (IDA & IBRD)
How they compare
Nauru currently reports 99.0% against 92.2% in South Asia (IDA & IBRD), a difference of 6.8%.
That makes Nauru's figure about 1.1 times South Asia (IDA & IBRD)'s.
Across all 24 years both countries report, Nauru has been ahead every year.
Nauru ranks 1st and South Asia (IDA & IBRD) ranks 3rd of 178 countries.
Nauru has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Nauru | South Asia (IDA & IBRD) | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 83.0% | 1.1% | 81.9% | Nauru |
| 2010s | 93.7% | 57.5% | 36.2% | Nauru |
| 2020s | 98.6% | 87.8% | 10.8% | Nauru |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher immunization, measles second dose, Nauru or South Asia (IDA & IBRD)?
- Nauru, at 99.0% against 92.2% in South Asia (IDA & IBRD) as of 2024.
- What is the difference in immunization, measles second dose between Nauru and South Asia (IDA & IBRD)?
- 6.8%, with Nauru ahead.
- How many years of comparable data are there for Nauru and South Asia (IDA & IBRD)?
- 24 years are reported by both, from 2001 to 2024.
- How do Nauru and South Asia (IDA & IBRD) rank globally for immunization, measles second dose?
- Nauru ranks 1st and South Asia (IDA & IBRD) ranks 3rd of 178 countries.
- Where does this data come from?
- WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/), published as Immunization, measles second dose (% of children by the nationally recommended age). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Child immunization, measles second dose, measures the percentage of children who received two dose of measles containing vaccine according to nationally recommended schedule through routine immunization services in a given year.